Comparisons of halogenated ß-nitrostyrenes as antimicrobial agents by Cornell, H et al.
?Thank
?
??????
???????
??????
?
?
Citatio
See th
Version
Copyri
Link to
??
?
you for do
??????????
??????????
??????????
n: 
is record i
:
ght Statem
 Published
?
wnloading
??????????
?????????????
??????????????????????????????????????????
n the RMI
ent: ©  
 Version:
 this docum
????????????
??????????
T Researc
ent from 
??????????
?
h Reposit
the RMIT R
??????????
ory at:  
esearch R
??????????
epository
??????????
????
??
PLEASE DO NOT REMOVE THIS PAGE
Cornell, H, Nguyen, T, Nicoletti, A, Jackson, N and Hugel, H 2014, 'Comparisons of
halogenated ß-nitrostyrenes as antimicrobial agents', Applied Sciences, vol. 4, no. 3, pp.
380-389.
https://researchbank.rmit.edu.au/view/rmit:24436
Published Version
2014 by the authors; licensee MDPI, Basel, Switzerland.
http://dx.doi.org/10.3390/app4030380
This article is an open access article distributed under the terms and conditions of 
the Creative Commons Attribution license 
http://creativecommons.org/licenses/by/3.0/. 
Appl. Sci. 2014, 4, 380-389; doi:10.3390/app4030380 
 
applied sciences 
ISSN 2076-3417 
www.mdpi.com/journal/applsci 
Article 
Comparisons of Halogenated β-Nitrostyrenes as  
Antimicrobial Agents 
Hugh Cornell, Thu Nguyen, Gina Nicoletti, Neale Jackson and Helmut Hügel * 
Health Innovations Research Institute & School of Applied Sciences RMIT University, Melbourne, 
VIC 3001, Australia; E-Mails: humarg1@hotmail.com (H.C.); ngocthu5848@yahoo.com.au (T.N.); 
ambrogina.nicoletti@gmail.com (G.N.); neale.jackson@rmit.edu.au (N.J.) 
* Author to whom correspondence should be addressed; E-Mail: helmut.hugel@rmit.edu.au;  
Tel.: +61-3-9925-2626; Fax: +61-3-9925-3747. 
Received: 7 July 2014; in revised form: 22 August 2014 / Accepted: 22 August 2014 /  
Published: 29 August 2014 
 
Abstract: The influence of three types of halogen-substituted E-β-methyl-β-nitrostyrenes 
(such as Compounds B, D, H) to overcome bacterial activity that is currently a significant 
health threat was studied. The evaluations of their bio-potency was measured and related to 
their structure and activity relationships for the purposes of serving to inhibit and 
overcoming resistant microorganisms. In particular, fluorine-containing β-nitrostyrenes 
were found to be highly active antimicrobial agents. The addition of the β-bromo group 
enhanced the antibacterial activity significantly. Our work has illustrated that halogen 
substituents at both the 4-position in the aromatic ring and also at the β-position on  
the alkene side chain of nitropropenyl arenes enhanced the antimicrobial activity of  
these compounds. 
Keywords: antimicrobial agents; medicinal chemistry; halogenated  
β-methyl-β-nitrostyrenes; Minimum Inhibitory Concentration 
 
1. Introduction 
An alarming analysis revealed that in 2007, more than 1500 people in Europe died from an invasive 
infection caused by a strain of Escherichia coli that was resistant to third-generation cephalosporins 
and originated in poultry [1]. Furthermore the mortality from carbapenem-resistant Enterobacteriaceae 
(CREs) is anticipated to be even higher should it spread in poultry on an equivalent scale, becoming a 
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major threat to human health in the world. Currently, no reliable treatment is available for humans 
infected with CREs. As these antibiotic-resistant bacterial pathogens are already entering the food 
chain [2,3] and can be transmitted through oral consumption [4], a call has been made for  
zero-tolerance on CREs in retail food to stop the situation from getting out of control. Unfortunately, 
the regulations on antimicrobial usage are largely ineffective, because they function only at a national 
level, whereas antimicrobial consumption and sales are global. An international/global ban on the sale 
of food items containing CREs could make imported and locally produced food meet the same standards. 
The health risks and consequences of the spread of these enterobacterial potential illnesses and 
diseases are enormous, and every effort must be made to prevent their increase to endemic proportions, 
especially for vulnerable individuals in communities and their threat to human life. Therefore, greater 
scientific efforts are urgently needed to focus on finding effective generic antibacterial agents. 
An analysis carried out in the United Kingdom predicts that if antibiotics become ineffective, 
everyday operations, such as hip replacements, could be fatal for around one in six [5]. 
Nitrostyrene derivatives have attracted considerable attention for the past several decades due to 
their diverse biological activities [6,7]. The resurgence of interest in the antibacterial activity of 
nitrovinyl containing compounds, including β-nitrostyrene derivatives, is attributed to their ready 
synthesis and significant antibacterial/antifungal activity with applications in veterinary and  
human medicine [8]. 
The introduction of the styryl functionality at position 2 of 5-nitroimidazoles potently enhanced the 
antimicrobial/antigiardial activity having low cytotoxicity against Giardia lamblia [9]. Indeed, an 
extensive SARs study of 5-nitroimidazoles related to metronidazole has uncovered compounds with 
improved drug activities against several clinically important microbes and unexpectedly overcame 
different forms of resistance. The positive performance of some of these research products in 
experimental disease testing has been promising. They could lead to better health outcomes [10].  
The dibrominated nitrovinylfurans, 2-bromo-5-(2-bromo-2-nitrovinyl)furan [11], showed  
broad-spectrum antibacterial activity against Gram-positive (multi-resistant strains of Staphylococcus 
aureus) and Gram-negative bacteria with a minimum inhibitory concentration (MIC) of 4 μg/mL or 
less. Reactions of the dibromo-nitrovinylfuran with proteins and glutathione (GSH) indicated that the  
intermediate thiol adducts reacted further with GSH to give glutathione disulfide and the  
mono-bromo-nitrovinylfuran, as shown in Scheme 1. 
Scheme 1. Michael addition of GSH to dibromo-nitrovinylfuran. 
 
Our previous research on the structure activity relationships (SARs) of nitrostyrene derivatives for 
antibacterial activity revealed that the presence of a fluorine atom at the para position on the benzene 
ring showed the highest activity against Gram-negative bacteria [12,13]. The aim of the present 
research work is to study the effect of various halogen substitutions at different ring and side chain 
positions of β-nitrostyrene derivatives on antibacterial activity. 
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2. Experimental Section 
2.1. Methods and Materials 
Three assays, as previously described [12,13], were used to determine the antibacterial efficacy of 
the β-nitrostyrenes by their activity against a panel of 4 bacteria and a fungus (Candida albicans). The 
results appear as the minimum inhibitory concentration (MIC) for each compound and are presented in 
the Tables 1 and 2. The chemical structures of the test compounds are shown in Figure 1. 
Figure 1. The structures of the E-β-nitrostyrene derivative test compounds. 
 
The three assays were performed as follows: 
Assay 1. The testing of the effect of the 2,2-difluoro-3,4-methylenedioxy substituent (B) on  
3,4-methylenedioxy-β-nitrostyrene (A) and on 3,4-methylenedioxy-β-methyl-β-nitrostyrene (A-1).  
A-1 was used for comparative purposes in the same assay. 
Assay 2. The testing of 4-bromo β-nitrostyrene (C) and 4-bromo-β-methyl-β-nitrostyrene (D) 
derivatives compared against 4-chloro-β-methyl-β-nitrostyrene (F) and β-bromo-β-nitrostyrene (H). 
The β-nitrostyrene E and A-1 were used for comparative purposes in the same assay. 
Assay 3. The comparison of the antibacterial activities of the halogen substituents, F-, Br- and Cl-, 
at the para position of the benzene ring of nitrostyrenes. 
All commercial chemicals and reagents used were of analytical reagent quality. The prepared 
purified compounds exhibited sharp melting points. Reactions were monitored by thin layer 
chromatography using Merck 60 F254 silica gel plates in (3:1) isopropanol-H2O eluting solvent. All of 
the prepared compounds were found to be E-β-nitrostyrenes from NMR data and were also 
characterized by MS analysis, as previously described [12]. The compounds shown in Figure 1 were 
prepared according to published methods [12] and are briefly described here. 
3,4-Methylenedioxy-β-methyl-β-nitrostyrene (A-1) was prepared by piperidine-catalysed 
condensation of piperonal with nitroethane, as previously described [13]. 
2.2. General β-Nitrostyrene Synthesis Method 
A mixture of 1 equivalent of the aldehyde, nitroethane, (2 equivalents) 1-butylamine (0.03 g) and 
glacial acetic acid (0.03 g) was heated at 100 °C under reflux conditions for 2 h (reaction progress 
monitored by TLC). The cooled reaction mixture was concentrated under vacuum, extracted with ethyl 
acetate (10 mL) and the organic residue consecutively washed with dilute solutions of HCl  
(0.1 mol L−1) and NaOH (0.1 mol L−1). The organic phase was concentrated under vacuum, and the 
residue was recrystallized three times from 95% ethanol to furnish the product, melting point (MP) 
determined and characterized by spectrometric analysis. 
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2,2-Difluoro-5-[(1E)-2-nitroprop-1-en-1-yl] Benzodioxole (B): A mixture of 2,2-difluoro-5-
formylbenzodioxole (1.0 g, 5.3 mmol) and nitroethane (2.5 g) was reacted according to the general 
synthesis protocol to furnish a yellow powder, MP 65–66 °C, in a 65% yield. 
1H NMR (300 MHz, CDCl3): δH (ppm): 8.05 (s, 1H, H–C=C), 7.18–7.19 (multiplet, 3Ar–H),  
2.46 (s, 3H, C–H, E), 1.56 (s, 3H, C–H, Z). 13C NMR (300 MHz, CDCl3) δC (ppm): 148.0 (Ar),  
144.6 (Ar), 144.2 (Ar), 132.2 (CH–Ar), 131.6 (t, J = 257.2 Hz, C–F2), 128.5 (C=C, β carbon),  
126.5 (Ar), 131.6 (C=C, α carbon), 128.5 (Ar), 128.2 (Ar), 126.5 (CH–Ar), 110.5 (CH–Ar),  
110.0 (CH–Ar), 14. 0 (–CH3). B Hires mass spectrum GC/MS m/z (M+) C10H7F2NO5: calculated 
243.0338, found 243.0371. 
1-Bromo-4β-[(E)-2-nitroethenyl] Benzene (C): A mixture of 4-bromobenzaldehyde (0.74 g,  
4 mmol) and nitromethane (0.5 g, 8 mmol) was reacted according to the general synthesis protocol to 
furnish yellow crystals, MP 145–146 °C in a 33% yield. GC/MS m/z (M+) 228. 
1-Bromo-4β-[(1E)-2-nitroprop-1-en-1-yl] Benzene (D): A mixture of 4-bromobenzaldehyde  
(0.93 g, 5 mmol) and nitroethane (0.6 g, 8 mmol) was reacted according to the general synthesis 
protocol to furnish yellow crystals, MP 148–149 °C, in a 24% yield. GC/MS m/z (M+) 242. 
[(E)-2-nitroethenyl] Benzene (E): A mixture of benzaldehyde (0.42 g, 4 mmol) and nitromethane 
(0.49 g, 8 mmol) was reacted according to the general synthesis protocol to furnish yellow crystals, 
MP 51–52 °C, in a 24% yield. GC/MS m/z (M+) 149. 
1-Chloro-4β-[(1E)-2-nitroprop-1-en-1-yl] Benzene (F): A mixture of 4-chlorobenzaldehyde  
(0.70 g, 5 mmol) and nitroethane (0.6 g, 8 mmol) was reacted according to the general synthesis 
protocol to furnish yellow crystals, MP 89–91 °C, in a 25% yield. 
1H NMR (300 MHz, CDCl3): δH (ppm): 8.05 (s, 1H, H–C=C), 7.28–8.05 (multiplet, 4Ar–H),  
2.46 (s, 3H, C–H, E), 1.55 (s, 3H, C–H, Z). 13C NMR (300 MHz, CDCl3) δC (ppm): 148.1 (Ar),  
136.1 (Ar), 132.2 (Ar), 131.2 (CH–Ar), 130.9 (CH–Ar), 129.3 (CH–Ar), 14. 0 (–CH3).  
GC/MS m/z (M+) 197. 
[(E)-2-Nitropropenyl] Benzene (G): A mixture of benzaldehyde (0.53 g, 5 mmol) and nitroethane 
(0.6 g, 8 mmol) was reacted according to the general synthesis protocol to furnish yellow crystals,  
MP 60–62 °C, in a 26% yield. GC/MS m/z (M+) 163. 
[2-Bromo-(E)-2-nitroethenyl] Benzene (H): A mixture of benzaldehyde (1.06 g, 10 mmol), 
bromonitromethane (1.0 g, 7 mmol), glacial acetic acid (0.05 g) and NH4OAc (0.19 g) was heated at 
100 °C under reflux conditions for 2 h (reaction progress monitored by TLC). The cooled reaction 
mixture was concentrated under vacuum, extracted with ethyl acetate (10 mL) and the organic residue 
consecutively washed with dilute solutions of HCl (0.1 mol L−1) and NaOH (0.1 mol L−1). The organic 
phase was concentrated under vacuum, and the residue was recrystallized three times from  
95% ethanol to furnish orange flakes, MP 61–62 °C, in a 20% yield. 
1H NMR (300 MHz, CDCl3): δH (ppm): 8.67 (s, 1H, H–C=C), 7.89–7.93 (multiplet, 2H, 2Ar–H), 
7.48–7.56 (multiplet, 3H, 3Ar–H), 13C NMR (300 MHz, CDCl3) δC (ppm): 136.5 (1CH=C),  
131.9 (1CH–Ar), 130.9 (2CH–Ar), 130.2 (Ar), 128.1 (Ar). GC/MS m/z (M+) 228. 
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1-Fluoro-4β-[(1E)-2-nitroprop-1-en-1-yl] benzene (I) was prepared as previously described [13]. 
Compound I was prepared in a 30% yield, yellow crystals, MP 65–66 °C. 1H NMR (300 MHz, 
CDCl3): δH (ppm): 8.06 (s, 1H, H–C=C), 7.46 (dd, J = 3.30, 5.37 Hz, 2H, Ar–H), 7.17 (t, J = 8.66 Hz, 
2H, Ar–H), 2.46 (s, 3H, C–H, E), 1.59 (s, 3H, C–H, Z). 13C NMR (300 MHz, CDCl3) δC (ppm):  
165.2 (d, J = 252.21 Hz, 1C, C–F), 147.5 (C=C, β carbon), 132.5 (C=C, α carbon), 132.2 (Ar),  
128.5 (Ar), 128.5 (Ar), 116.3 (Ar), 116.0 (Ar), 14 .0 (CH3). GC/MS m/z (M+) 181. 
3. Results and Discussion 
3.1. Analysis of Assays 
Assay 1. The effect of the two fluorine atoms in 2,2-difluoro-3,4-methylenedioxy-β-methyl-β-
nitrostyrene (B) reduced the antimicrobial activity compared to A-1. All of the test compounds  
showed very weak antimicrobial activity against E. coli. However, the activity of B against S. aureus 
and Bacillus subtilis was high and comparable to A-1 (refer to Table 1). The activity of  
2,2-difluoro-3,4-methylenedioxy-β-nitrostyrene was very weak compared with that of the same 
compound, including the β-methyl group (B), and therefore, the data were not included in Table 1. 
Table 1. Assays 1 and 2: minimum inhibitory concentrations (MICs) of  
β-nitrostyrene analogues. 
Strain A-1 B C D E F G H 
Staphylococcus aureus ATCC 29213 16 16 32 16 128 32 32 32 
Bacillus subtilis ATCC 6633 16 16 32 8 128 32 64 64 
Enterococcus faecalis ATCC 29212 32 512 64 64 128 256 128 128 
Escherichia coli ATCC 25922 362 512 197 181 362 128 128 128 
Candida albicans ATCC 10231 23 44 23 23 362 23 44 23 
Assay 2. The highest activity was observed with 4-bromo-β-methyl-β-nitrostyrene (D), which 
performed better than A-1 against E. coli and was comparable to A-1 against the other species. 
Compounds G and H also showed good all-round activity. Improvement in activity is also observed by 
substitution of a β-methyl group (G) or a β-bromine group (H) to Compound E. 
Compound C (4-bromo–β-nitrostyrene) also showed fairly high activity, except against E. coli.  
It is, however, more active that A-1, B and E against this species. Between Compounds D, F, G and H, D 
is clearly superior against Gram-positive species, but there is little difference in activity against  
C. albicans. The fact that D is better than F suggests that 4-bromo substitution leads to higher activity 
than 4-chloro substitution. Only the 4-bromo derivative (D) was more active than the parent compound (G) 
against Gram-positive bacteria. Only F (4-chloro-), G (β-methyl) and H (β-bromo) derivatives gave 
satisfactory activity against the Gram-negative E. coli. Compounds C (4-bromo) and D  
(4-bromo-β-methyl), derivatives of nitrostyrene, are still significantly better than the methylenedioxy 
derivative (A-1) (refer to Table 1). The same comments apply to Compound I, which is evaluated in 
Assay 3. This compound has been evaluated in different assays, and the results in Table 3 are from an 
assay in which I was evaluated against 4-fluoro-β-nitrostyrene (without the β-methyl group), which 
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showed that I was much better than 4-fluoro-β-nitrostyrene and also A-1. In all of our work, we have 
found this to be the case (see [12,13]). 
Table 1 shows the MICs in μg mL−1 of β-nitrostyrene analogues tested against four strains of 
bacteria and a fungus. The values are the geometric means of two determinations. In our MIC data, the 
geometric mean represents a mean or average, indicative of the central tendency or typical value of 
duplicate-measured MIC values by using the product of their values. It is defined as the ½ root of the 
product of two determinations [14]. 
Assay 3. In the third assay, 4-fluoro-β-methyl-β-nitrostyrene showed comparable activity to A-1, 
with the advantage against E. coli, but this was offset by lower activity against E. faecalis. No real 
advantage of fluorine over chlorine or bromine substitution could be claimed (refer to Table 2).  
All compounds showed equivalent activity to A-1 against the bacteria and the fungus. 
Table 2. Assay 3: MICs of halogenated derivatives I, D and F compared against A-1. 
Strain A-1 I D F 
Staphylococcus aureus ATCC 29213 32 32 32 32 
Bacillus subtilise ATCC 6633 16 16 16 32 
Enterococcus faecalis ATCC 29212 64 128 128 256 
Escherichia coli ATCC 25922 512 256 256 128 
Candida albicans ATCC 10231 32 32 32 32 
Table 2. Assay 3: MICs in μg mL−1 of the halogenated derivatives of β-methyl-β-nitrostyrene 
compared against A-1 using four strains of bacteria and a fungus. The values are the geometric means 
of two determinations. Note: Assays 1, 2 and 3 were all within the ciprofloxacin acceptable range for 
S. aureus, E. faecalis and E. coli. 
3.2. Mechanism of Antibacterial Activity 
Nicoletti et al. [13,15] investigated the MIC to bacteria and fungi of 20 compounds based on the  
β-nitrostyrene scaffold to bacteria and fungi and found that they were broadly antimicrobial, with 
greater activity overall against Gram-positive bacteria and fungi. Whilst it was established from SAR 
studies that their lipophilic and the nucleophilic addition of thiol groups to the nitroolefin are the key 
physicochemical features, their antimicrobial mechanisms are not well understood.  
Various β-nitrostyrene derivatives are used as tyrosine kinase inhibitors with applications in potent 
antiplatelet activity [16,17]. Furthermore, pronounced substituent effects were observed. Specific 
mono- and di-substitutions on the aromatic ring of β-nitrostyrene tended to increase the anti-platelet 
activity and decrease the cytotoxic activity [17]. 3,4-Methylenedioxy-β-nitrostyrene (MNS) blocks  
the assembly of NLRP3 inflammasome by the inhibition of NLRP3 ATPase activity [18,19].  
The nitrovinyl group is essential for the inhibitory activity of MNS. 
The enzyme 4-oxalocrotonate tautomerase (4-OT), which contains an amino-terminal proline 
(Pro1), promiscuously catalyses the asymmetric Michael-type additions of aldehydes and ketone 
donors to β-nitrostyrene to yield γ-nitroaldehydes, with 89% enantiomeric excess [20]. Significantly, 
this Michael addition reaction has been designed and performed in vivo in resting E. coli BL21 whole 
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cells expressing 4-OT. This implies that the β-nitrostyrene used in the context as a reactant/substrate 
had no antibacterial effect on the host E. coli BL21 cells [21]. 
Park and Pei [22] proposed that their nitroalkenyl aromatic compounds act as tyrosine mimetics, 
thereby inhibiting protein tyrosine phosphatases and interfering with downstream cell signaling in 
microorganisms. They proposed that β-nitrostyrene acts as a reversible inhibitor of this enzyme by 
interaction and formation of a covalent complex via nucleophilic attack of PTP1B cysteine on the  
β-nitro group at the catalytic site. However, sulphur ylides, like thiol nucleophiles, are found to 
undergo Michael addition to a wide range of β-nitrostyrenes [23–26]. The known reactivity of  
β-nitrostyrenes with sulfhydryl groups is consistent with these observations. A more attractive 
mechanistic proposal is that the conjugated nitroalkene is a good Michael acceptor of nucleophiles 
owing to the non-covalent binding capability of the nitro group with PTP1B, as shown in  
Scheme 2 below. 
Scheme 2. Modified Michael addition mechanism: E-β-nitrostyrene-PTP1B binding 
complex and inhibition mechanism. 
 
Furthermore, in contrast to what was reported by Park and Pei, research published by  
Milhazes et al. [27] and supported from our work [12,13] found that the antibacterial activity was 
substantially improved by the addition of a β-methyl group, as shown by the MIC comparisons in 
Table 3. The β-methyl group would be expected to enhance the above mechanism [12]. 
Table 3 shows the enhanced antibacterial activity (MIC values) of Compound I by the introduction 
of the β-methyl group to 4-F-nitrostyrene [12]. The values are the geometric means of two determinations. 
Table 3. Comparative MIC (μg/mL) values of 4-F-nitrostyrene and Compound I. 
Strain 
  
Staphylococcus aureus 128 2 
Bacillus subtilis 256 2 
Enterococcus faecalis 64 5.5 
Escherichia coli 256 27 
Candida albicans 32 2 
3.3. Summary of SARs of the Antimicrobial Activity of Nitrostyrenes 
a. The fluorination of the methylenedioxy substituent of A-1 and Compound A was 
counterproductive in improving the bioactivity of A-1 against all organisms. 
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b. The highest antimicrobial activity was found with Compound D (4-bromo-β-methyl-β-nitrostyrene), 
which gave good protection against most strains, except E. coli; however, it performed better than A-1, 
which was poor against E. coli. Compound D gave good protection against S. aureus, B. subtilis and  
C. albicans, but only marginal protection against E. faecalis. 
c. Furthermore, Compound D gave identical results to I (4-fluoro-β-methyl-β-nitrostyrene), 
supporting previous data that I is superior to A-1, although still not being very effective against E. coli. 
d. The relative effects of halogen substitution at the 4-position (Compounds D, F and I) indicate 
small differences from substitution by Br-, Cl- and F- for protection against the microorganisms tested. 
e. The substitution of Br- for CH3 at the β-carbon side chain (Compounds G and H) gave almost 
identical results for all strains, except for C. albicans. Good protection was provided by Compound H 
against this fungus. 
f. The parent compound, β-nitrostyrene (E), was found to offer little antimicrobial protection 
against all strains, justifying the testing of β-nitrostyrene derivatives, and it was the least effective 
antibacterial of all compounds tested. 
4. Conclusions 
The predominant reaction of β-nitrostyrenes to undergo Michael addition reactions with 
nucleophiles, such as cysteine sulfhydryls, thiols, aldehydes and biocatalysts, may be a feature of their 
general biological activity, including their antimicrobial mode of activity, particularly their inhibition 
of cysteine-rich enzyme systems. Additional β-substitution by methyl or bromine significantly 
enhances the antimicrobial activity of β-nitrostyrenes consistent with that reported by others for 
nitrovinylfurans, and this supports the Michael addition reaction mechanism. From our previous SAR 
studies and from this work, we have found that the nature of the substituents on the aromatic ring plays 
a major role in the efficacy of the microbial toxicity of β-methyl-β-nitrostyrenes. 
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